KIT and myelodysplastic syndrome: AMG 191, a clinical-grade CD117 antibody, depleted myelodysplastic syndrome (MDS) HSCs in mouse models and is currently being evaluated in clinical trials for pediatric SCID (De Franceschi et al., 2019).